Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Merck faces another round of criticism

Philadelphia Inquirer, August 19, 2008

For the third time in three years, a prominent medical journal has criticized Merck & Co. Inc. for misrepresenting research on its pain reliever Vioxx. The editors of the Annals of Internal Medicine said the journal's findings may point to a broader problem in the pharmaceutical industry. Drug companies have long been suspected of enlisting doctors in trials solely to get doctors in the "habit of prescribing a new drug," the editors said. These are known as "seeding" trials, and the editorial says such trials pay doctors involved in them to consult with the drug company plus a fee for each patient they enroll.